Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Seppälä H[au]:

Search results

Items: 38

1.

Interplay between Short-Range Attraction and Long-Range Repulsion Controls Reentrant Liquid Condensation of Ribonucleoprotein-RNA Complexes.

Alshareedah I, Kaur T, Ngo J, Seppala H, Kounatse LD, Wang W, Moosa MM, Banerjee PR.

J Am Chem Soc. 2019 Sep 18;141(37):14593-14602. doi: 10.1021/jacs.9b03689. Epub 2019 Sep 5.

PMID:
31437398
2.

BK polyomavirus microRNA expression and sequence variation in polyomavirus-associated nephropathy.

Virtanen E, Seppälä H, Helanterä I, Laine P, Lautenschlager I, Paulin L, Mannonen L, Auvinen P, Auvinen E.

J Clin Virol. 2018 May;102:70-76. doi: 10.1016/j.jcv.2018.02.007. Epub 2018 Feb 12.

3.

HIV-1 transmission networks in high risk fishing communities on the shores of Lake Victoria in Uganda: A phylogenetic and epidemiological approach.

Kiwuwa-Muyingo S, Nazziwa J, Ssemwanga D, Ilmonen P, Njai H, Ndembi N, Parry C, Kitandwe PK, Gershim A, Mpendo J, Neilsen L, Seeley J, Seppälä H, Lyagoba F, Kamali A, Kaleebu P.

PLoS One. 2017 Oct 12;12(10):e0185818. doi: 10.1371/journal.pone.0185818. eCollection 2017.

4.

Archetype JC Polyomavirus (JCPyV) Prevails in a Rare Case of JCPyV Nephropathy and in Stable Renal Transplant Recipients With JCPyV Viruria.

Seppälä HM, Helanterä IT, Laine PKS, Lautenschlager IT, Paulín LG, Jahnukainen TJ, Auvinen POV, Auvinen E.

J Infect Dis. 2017 Nov 15;216(8):981-989. doi: 10.1093/infdis/jix435.

PMID:
28968776
5.

Single-Molecule Sequencing Revealing the Presence of Distinct JC Polyomavirus Populations in Patients With Progressive Multifocal Leukoencephalopathy.

Seppälä H, Virtanen E, Saarela M, Laine P, Paulín L, Mannonen L, Auvinen P, Auvinen E.

J Infect Dis. 2017 Mar 15;215(6):889-895. doi: 10.1093/infdis/jiw399.

PMID:
28453853
6.

Borderline intellectual functioning: a systematic literature review.

Peltopuro M, Ahonen T, Kaartinen J, Seppälä H, Närhi V.

Intellect Dev Disabil. 2014 Dec;52(6):419-43. doi: 10.1352/1934-9556-52.6.419. Review.

PMID:
25409130
7.

Mondo/ChREBP-Mlx-regulated transcriptional network is essential for dietary sugar tolerance in Drosophila.

Havula E, Teesalu M, Hyötyläinen T, Seppälä H, Hasygar K, Auvinen P, Orešič M, Sandmann T, Hietakangas V.

PLoS Genet. 2013 Apr;9(4):e1003438. doi: 10.1371/journal.pgen.1003438. Epub 2013 Apr 4.

8.

The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes.

Jaakkola U, Kakko T, Seppälä H, Vainio-Jylhä E, Vahlberg T, Raitakari OT, Kallio J.

Microvasc Res. 2010 Dec;80(3):433-9. doi: 10.1016/j.mvr.2010.07.010. Epub 2010 Aug 5.

PMID:
20691708
9.

Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes.

Jaakkola U, Koulu M, Karvonen MK, Seppälä H, Pesonen U, Vahlberg T, Kallio J.

Exp Clin Endocrinol Diabetes. 2007 May;115(5):281-6.

PMID:
17516289
10.

Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.

Bergman M, Huikko S, Huovinen P, Paakkari P, Seppälä H; Finnish Study Group for Antimicrobial Resistance (FiRe Network).

Antimicrob Agents Chemother. 2006 Nov;50(11):3646-50. Epub 2006 Aug 28.

11.

Streptococcus pneumoniae isolates resistant to telithromycin.

Rantala M, Haanperä-Heikkinen M, Lindgren M, Seppälä H, Huovinen P, Jalava J.

Antimicrob Agents Chemother. 2006 May;50(5):1855-8.

12.

EMMPRIN and MMP-1 in keratoconus.

Seppälä HP, Määttä M, Rautia M, Mackiewicz Z, Tuisku I, Tervo T, Konttinen YT.

Cornea. 2006 Apr;25(3):325-30. Erratum in: Cornea. 2006 Jul;25(6):760.

PMID:
16633034
13.

Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization.

Koulu M, Movafagh S, Tuohimaa J, Jaakkola U, Kallio J, Pesonen U, Geng Y, Karvonen MK, Vainio-Jylhä E, Pöllönen M, Kaipio-Salmi K, Seppälä H, Lee EW, Higgins RD, Zukowska Z.

Ann Med. 2004;36(3):232-40.

PMID:
15181979
14.

Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.

Bergman M, Huikko S, Pihlajamäki M, Laippala P, Palva E, Huovinen P, Seppälä H; Finnish Study Group for Antimicrobial Resistance (FiRe Network).

Clin Infect Dis. 2004 May 1;38(9):1251-6. Epub 2004 Apr 14.

PMID:
15127336
15.

Effect of prophylactic antibiotics on antimicrobial resistance of viridans streptococci in the normal flora of cataract surgery patients.

Seppälä H, Al-Juhaish M, Järvinen H, Laitinen R, Huovinen P.

J Cataract Refract Surg. 2004 Feb;30(2):307-15.

PMID:
15030817
16.

Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora.

Seppälä H, Haanperä M, Al-Juhaish M, Järvinen H, Jalava J, Huovinen P.

J Antimicrob Chemother. 2003 Oct;52(4):636-44. Epub 2003 Sep 12.

PMID:
12972451
17.

Clonal relationships among isolates of erythromycin-resistant Streptococcus pyogenes of different geographical origin.

Kataja J, Huovinen P, Efstratiou A, Pérez-Trallero E, Seppälä H; Macrolide resistance study group.

Eur J Clin Microbiol Infect Dis. 2002 Aug;21(8):589-95. Epub 2002 Aug 15.

PMID:
12226689
18.

Ribosomal mutations in Streptococcus pneumoniae clinical isolates.

Pihlajamäki M, Kataja J, Seppälä H, Elliot J, Leinonen M, Huovinen P, Jalava J.

Antimicrob Agents Chemother. 2002 Mar;46(3):654-8.

19.

In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species.

Jalava J, Kataja J, Seppälä H, Huovinen P.

Antimicrob Agents Chemother. 2001 Mar;45(3):789-93.

20.

Erythromycin resistance genes in group A streptococci of different geographical origins. The Macrolide Resistance Study Group.

Kataja J, Huovinen P, Seppälä H.

J Antimicrob Chemother. 2000 Nov;46(5):789-92.

PMID:
11062199
21.

Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H.

Antimicrob Agents Chemother. 1999 Dec;43(12):2823-30. Review. No abstract available.

22.

Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.

Kataja J, Huovinen P, Skurnik M, Seppälä H.

Antimicrob Agents Chemother. 1999 Jan;43(1):48-52.

23.

Different erythromycin resistance mechanisms in group C and group G streptococci.

Kataja J, Seppälä H, Skurnik M, Sarkkinen H, Huovinen P.

Antimicrob Agents Chemother. 1998 Jun;42(6):1493-4.

24.

A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.

Seppälä H, Skurnik M, Soini H, Roberts MC, Huovinen P.

Antimicrob Agents Chemother. 1998 Feb;42(2):257-62.

25.

Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance.

Kataja J, Huovinen P, Muotiala A, Vuopio-Varkila J, Efstratiou A, Hallas G, Seppälä H.

J Infect Dis. 1998 Mar;177(3):786-9.

PMID:
9498465
26.

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.

Seppälä H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, Huovinen P.

N Engl J Med. 1997 Aug 14;337(7):441-6.

27.

Erythromycin resistance of group A streptococci from throat samples is related to age.

Seppälä H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P.

Pediatr Infect Dis J. 1997 Jul;16(7):651-6.

PMID:
9239768
28.

Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland.

Muotiala A, Seppälä H, Huovinen P, Vuopio-Varkila J.

J Infect Dis. 1997 Feb;175(2):392-9.

PMID:
9203660
29.

The relationship between erythromycin consumption and resistance in Finland. Finnish Study Group for Antimicrobial Resistance.

Huovinen P, Seppălä H, Kataja J, Klaukka T.

Ciba Found Symp. 1997;207:36-41; discussion 41-6. Review.

PMID:
9189633
30.

Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci.

Seppälä H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P.

Clin Infect Dis. 1995 Dec;21(6):1378-85.

PMID:
8749619
31.

Specialized family care for children with developmental disabilities: the Finnish experience.

Szymanski LS, Seppala HT.

Child Welfare. 1995 Mar-Apr;74(2):367-81.

PMID:
7705171
33.

Typing of group A streptococci by random amplified polymorphic DNA analysis.

Seppälä H, He Q, Osterblad M, Huovinen P.

J Clin Microbiol. 1994 Aug;32(8):1945-8.

34.

Evaluation of methods for epidemiologic typing of group A streptococci.

Seppälä H, Vuopio-Varkila J, Osterblad M, Jahkola M, Rummukainen M, Holm SE, Huovinen P.

J Infect Dis. 1994 Mar;169(3):519-25.

PMID:
7908926
35.

Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.

Seppälä H, Nissinen A, Yu Q, Huovinen P.

J Antimicrob Chemother. 1993 Dec;32(6):885-91. No abstract available.

PMID:
8144429
36.

Clinical scoring system in the evaluation of adult pharyngitis.

Seppälä H, Lahtonen R, Ziegler T, Meurman O, Hakkarainen K, Miettinen A, Arstila P, Eskola J, Saikku P, Huovinen P.

Arch Otolaryngol Head Neck Surg. 1993 Mar;119(3):288-91.

PMID:
8435167
37.

Resistance to erythromycin in group A streptococci.

Seppälä H, Nissinen A, Järvinen H, Huovinen S, Henriksson T, Herva E, Holm SE, Jahkola M, Katila ML, Klaukka T, et al.

N Engl J Med. 1992 Jan 30;326(5):292-7.

38.

Outut characteristics compared between combined and separate apex indicators and pulp vitality testers.

Meurman JH, Koskinen KP, Seppälä H.

Proc Finn Dent Soc. 1980;76(1):20-4. No abstract available.

PMID:
7384062

Supplemental Content

Loading ...
Support Center